Ignite Creation Date:
2024-05-06 @ 2:48 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02132351
Status:
COMPLETED
Last Update Posted:
2016-04-11
First Post:
2014-05-05
Brief Title:
Hepatic Fibrosis Non-invasive Methods Questionnaire
Sponsor:
Al-Azhar University
Organization:
Al-Azhar University
Study Overview
Official Title:
Acceptability Reliability and Applicability of Liver Biopsy and Noninvasive Methods for Assessment of Hepatic Fibrosis and Cirrhosis Among Hepatologists a Web Based Survey
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Due to the limitations and the invasive nature of liver biopsy there has been extensive interest in developing non-invasive tests to measure liver fibrosis 1 These are alternatives to liver biopsy that can be used in clinical practice with benefits in terms of cost risk and patient convenience 2 Clinically applicable non-invasive tests include radiological studies transient elastography TE and serum markers We aim at studying acceptability reliability applicability and practical aspects of invasive and noninvasive methods for assessment of hepatic fibrosis and cirrhosis among hepatologists
Detailed Description:
Due to the limitations and the invasive nature of liver biopsy there has been extensive interest in developing non-invasive tests to measure liver fibrosis 1 These are alternatives to liver biopsy that can be used in clinical practice with benefits in terms of cost risk and patient convenience 2 Clinically applicable non-invasive tests include radiological studies transient elastography TE and serum markers We aim at studying acceptability reliability applicability and practical aspects of invasive and noninvasive methods for assessment of hepatic fibrosis and cirrhosis among hepatologists
Methods
The study is a survey study among hepatologists Four thousand hepatologists will be invited to participate in the questionnaire through e-mail invitations to answer 50 questions of the questionnaire The questionnaire will be hosted on Survey monkey website and results will be analyzed to get the consensus opinion of participants for the use of invasive and non-invasive methods for assessment of hepatic fibrosis and cirrhosis and factors affecting their preferences
Statistical analysis plan Analysis of data will be performed using Statistical Package for Scientific Studies 17 for Windows Description of qualitative variables will be in the form of numbers No and percent Description of quantitative variables will be in the form of mean standard deviation SD Questionnaire results will be compared against different baseline characteristics of the studied group According to the type and distribution of data suitable tests for inferential statistics will be used Significance of the results will be presented in the form of P-value
Methods
The study is a survey study among hepatologists Four thousand hepatologists will be invited to participate in the questionnaire through e-mail invitations to answer 50 questions of the questionnaire The questionnaire will be hosted on Survey monkey website and results will be analyzed to get the consensus opinion of participants for the use of invasive and non-invasive methods for assessment of hepatic fibrosis and cirrhosis and factors affecting their preferences
Statistical analysis plan Analysis of data will be performed using Statistical Package for Scientific Studies 17 for Windows Description of qualitative variables will be in the form of numbers No and percent Description of quantitative variables will be in the form of mean standard deviation SD Questionnaire results will be compared against different baseline characteristics of the studied group According to the type and distribution of data suitable tests for inferential statistics will be used Significance of the results will be presented in the form of P-value
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AlazharU-MB-1 | OTHER | AlazharU-MB | None |